We are live on
!
Find out more
Rocket Pharmaceuticals
RCKT
RCKT
58 hedge funds and large institutions have $141M invested in Rocket Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
600% more call options, than puts
Call options by funds: $7K | Put options by funds: $1K
86% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 14
3% less funds holding
Funds holding: 60 → 58 (-2)
20% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 10
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
35% less capital invested
Capital invested by funds: $218M → $141M (-$76.8M)
Holders
58
Holders Change
-2
Holders Change %
-3.33%
% of All Funds
1.55%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
8
Increased
26
Reduced
14
Closed
10
Calls
$7K
Puts
$1K
Net Calls
+$6K
Net Calls Change
-$31K
Top Buyers
| 1 |
O
OrbiMed
New York
|
+$7.25M |
| 2 |
SAM
Senzar Asset Management
New York
|
+$3.29M |
| 3 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$1.14M |
| 4 |
FO
FT Options
Chicago,
Illinois
|
+$1.07M |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$646K |
